Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Sunday, May 15, 2016

Functions and Mechanisms of Microglia/Macrophages in Neuroinflammation and Neurogenesis during Stroke

How EXACTLY is your doctor going to use this to help your recovery? Any hemming and hawing in the answer is grounds for firing.
http://www.sciencedirect.com/science/article/pii/S030100821630003X
Choose an option to locate/access this article:
Check if you have access through your login credentials or your institution
Check access

Highlights

We discuss microglial and macrophage morphologies and phenotypic changes in response to acute brain damage and repair in the context of stroke.
Given these modifiable and adaptable functions of microglia/macrophages, we argue that future translational studies should be targeting multiple key regulating molecules involved in changes in microglia/macrophage activation and polarization and that the studies should incorporate the concept of a “therapeutic time window” for sequential therapies.
We also give some suggestions for further research, such as constructing new experimental stroke models, identifying new gene signatures for circulating immune cells when they enter into the CNS, and exploring the endogenous neuroprotective mechanisms responsible for brain repair, which may quicken the forward pace of research.

Abstract

Microglia/macrophages are the major immune cells involved in the defence against brain damage. Their morphology and functional changes are correlated with the release of danger signals induced by stroke. These cells are normally responsible for clearing away dead neural cells and restoring neuronal functions. However, when excessively activated by the damage-associated molecular patterns following stroke, they can produce a large number of proinflammatory cytokines that can disrupt neural cells and the blood-brain barrier and influence neurogenesis. These effects indicate the important roles of microglia/macrophages in the pathophysiological processes of stroke. However, the modifiable and adaptable nature of microglia/macrophages may also be beneficial for brain repair and not just result in damage. These distinct roles may be attributed to the different microglia/macrophage phenotypes because the M1 population is mainly destructive, while the M2 population is neuroprotective. Additionally, different gene expression signature changes in microglia/macrophages have been found in diverse inflammatory milieus. These biofunctional features enable dual roles for microglia/macrophages in brain damage and repair. Currently, it is thought that the proper inflammatory milieu may provide a suitable microenvironment for neurogenesis; however, detailed mechanisms underlying the inflammatory responses that initiate or inhibit neurogenesis remain unknown. This review summarizes recent progress concerning the mechanisms involved in brain damage, repair and regeneration related to microglia/macrophage activation and phenotype transition during stroke. We also argue that future translational studies should be targeting multiple key regulating molecules to improve brain repair, which should be accompanied by the concept of a “therapeutic time window” for sequential therapies.


No comments:

Post a Comment